Skip to content
★ Sign in to follow
GJ

George Jue

PDL Biopharma, Inc.Ardelyx, Inc.
Total declarations
7
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€177k

Latest filing published 04 Mar 2015 for Ardelyx, INC., €21k.

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

No signal scores available.

George Jue: trading record in brief

George Jue has filed trades across 2 companies (mainly through SEC (Form 4)), most often in PDL Biopharma, Inc. and Ardelyx, Inc. Over a trading history stretching from 8 November 2006 to 2 March 2015, the count stands at 7 filings.

Every open-market trade on record is a sale: 6 sales worth €177k. Other entries cover 1 option exercise. 2015 to date brings no purchases and 1 sale.

Most recently, on 4 March 2015, the filings show an open-market sale worth €21k in Ardelyx, Inc. The median gap between a trade and its publication by SEC (Form 4) is 8 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to George Jue

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▼
    VP, OperationsExecutivesArdelyx, Inc.
    23,820 USD0SEC
    1,500 shares@ US$15.88Common StockSEC:0001140361-15-010303:0
  • ◇
    VP of FinanceExecutivesPDL Biopharma, Inc.
    144,716 USD0SEC
    9,200 shares@ US$15.73Commom StockSEC:0001140361-06-016632:0
  • ▼
    VP of FinanceExecutivesPDL Biopharma, Inc.
    27,060 USD0SEC
    1,200 shares@ US$22.55Common StockSEC:0001140361-06-016632:1
  • ▼
    VP of FinanceExecutivesPDL Biopharma, Inc.
    43,000 USD0SEC
    2,000 shares@ US$21.50Common StockSEC:0001140361-06-016632:2
  • ▼
    VP of FinanceExecutivesPDL Biopharma, Inc.
    42,560 USD0SEC
    2,000 shares@ US$21.28Common StockSEC:0001140361-06-016632:3
  • ▼
    VP of FinanceExecutivesPDL Biopharma, Inc.
    42,800 USD0SEC
    2,000 shares@ US$21.40Common StockSEC:0001140361-06-016632:4
  • ▼
    VP of FinanceExecutivesPDL Biopharma, Inc.
    43,100 USD0SEC
    2,000 shares@ US$21.55Common StockSEC:0001140361-06-016632:5

7 of 7 declarations